The RAB7 GTPase activator ML-098 reduced severe PH in chronic hypoxia/SU5416 (Hx/Su) rats, thus identifying RAB7 as a potential therapeutic target in PAH. The gene discussed is RAB7A; the disease is pulmonary arterial hypertension.